The Middle EAST Cell-Free DNA (cfDNA) Testing Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of genetic disorders, rising awareness regarding non-invasive prenatal testing (NIPT), and advancements in cfDNA analysis...